UNICA IRIS Institutional Research Information System

CARUCCI, SARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 37.346
NA - Nord America 4.429
AS - Asia 2.470
SA - Sud America 440
Continente sconosciuto - Info sul continente non disponibili 236
AF - Africa 136
OC - Oceania 15
Totale 45.072
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 35.903
US - Stati Uniti d'America 4.243
SG - Singapore 1.013
CN - Cina 636
BR - Brasile 345
SE - Svezia 296
VN - Vietnam 269
FR - Francia 255
DE - Germania 176
FI - Finlandia 125
BD - Bangladesh 124
GB - Regno Unito 120
HK - Hong Kong 98
NL - Olanda 96
CA - Canada 94
ZA - Sudafrica 86
UA - Ucraina 85
IN - India 83
BE - Belgio 62
MX - Messico 43
CH - Svizzera 41
KR - Corea 32
RU - Federazione Russa 31
AR - Argentina 27
ID - Indonesia 25
TR - Turchia 23
AT - Austria 21
RO - Romania 21
CO - Colombia 20
ES - Italia 20
IQ - Iraq 19
JP - Giappone 18
PL - Polonia 18
MA - Marocco 17
AU - Australia 15
MY - Malesia 15
SA - Arabia Saudita 14
EC - Ecuador 13
PK - Pakistan 13
AE - Emirati Arabi Uniti 12
IR - Iran 12
JM - Giamaica 12
CL - Cile 11
IE - Irlanda 10
UZ - Uzbekistan 10
VE - Venezuela 10
DK - Danimarca 8
HN - Honduras 8
CR - Costa Rica 7
CZ - Repubblica Ceca 7
GR - Grecia 7
IL - Israele 7
KE - Kenya 7
KZ - Kazakistan 7
NO - Norvegia 7
LT - Lituania 6
DO - Repubblica Dominicana 5
EG - Egitto 5
LB - Libano 5
PT - Portogallo 5
PY - Paraguay 5
TN - Tunisia 5
BG - Bulgaria 4
BO - Bolivia 4
ET - Etiopia 4
HU - Ungheria 4
JO - Giordania 4
PH - Filippine 4
PS - Palestinian Territory 4
TH - Thailandia 4
AL - Albania 3
GT - Guatemala 3
HR - Croazia 3
LA - Repubblica Popolare Democratica del Laos 3
NI - Nicaragua 3
NP - Nepal 3
SN - Senegal 3
SY - Repubblica araba siriana 3
TW - Taiwan 3
AD - Andorra 2
BY - Bielorussia 2
EE - Estonia 2
KG - Kirghizistan 2
LV - Lettonia 2
LY - Libia 2
NG - Nigeria 2
PA - Panama 2
PE - Perù 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
DZ - Algeria 1
GD - Grenada 1
GE - Georgia 1
GN - Guinea 1
GY - Guiana 1
KH - Cambogia 1
Totale 44.825
Salva come PNG Salva come JPEG
Città #
Cagliari 32.147
Uta 1.774
Singapore 582
Ashburn 446
San Jose 301
Rome 234
Council Bluffs 199
Dallas 177
Boardman 162
Nyköping 159
Milan 152
Los Angeles 119
Fairfield 109
Chandler 108
New York 107
Beijing 103
Houston 99
Woodbridge 99
Santa Clara 91
Helsinki 86
Hong Kong 86
Ho Chi Minh City 81
Hefei 66
Johannesburg 62
The Dalles 58
Hanoi 55
Genk 50
Ann Arbor 47
Cambridge 45
Dearborn 45
Lauterbourg 45
Bari 44
Charleston 43
Jacksonville 43
Shanghai 43
Wilmington 43
Palermo 41
Seattle 40
Frankfurt am Main 39
Naples 39
Chicago 38
Columbus 38
Turin 38
São Paulo 35
Dong Ket 34
Florence 34
Orem 34
Bologna 33
Catania 32
Boston 28
Redondo Beach 28
San Francisco 28
Amsterdam 26
Seoul 26
Atlanta 25
Phoenix 25
Nanjing 24
Brooklyn 23
Buffalo 23
San Diego 23
Washington 23
Montreal 22
Munich 21
Nuremberg 21
Toronto 19
Denver 18
Brescia 17
Messina 17
Mexico City 17
Padova 17
Silver Spring 17
Bucharest 16
Castellammare di Stabia 15
Tokyo 15
Ancona 14
Cincinnati 14
Lappeenranta 14
London 14
Taranto 14
Perugia 13
Philadelphia 13
Rotterdam 13
Rustenburg 13
Stockholm 13
Calgary 12
Chennai 12
Da Nang 12
Genoa 12
Guangzhou 12
Parma 12
Charlotte 11
Haiphong 11
Tianjin 11
Trieste 11
Urbino 11
Utrecht 11
Warsaw 11
Zurich 11
Changsha 10
Louisville 10
Totale 39.434
Salva come PNG Salva come JPEG
Nome #
Effetti del Metilfenidato sulla crescita in bambini e adolescenti ADHD. Revisione sistematica e monitoraggio prospettico a lungo termine dei parametri auxologici: analisi preliminari dei risultati dello studio europeo di farmacovigilanza ADDUCE 2.237
Prospective observational study protocol to investigate long-term adverse effects of methylphenidate in children and adolescents with ADHD: The Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study 1.885
Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine 1.649
Neurological and psychiatric adverse effects of long-term methylphenidate treatment in ADHD: A map of the current evidence 1.610
Reports of Perceived Adverse Events of Stimulant Medication on Cognition, Motivation, and Mood: Qualitative Investigation and the Generation of Items for the Medication and Cognition Rating Scale 1.569
Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis 1.523
Effects of methylphenidate on height in ADHD children. The monitoring of bone age within the ADDUCE project 1.371
Effects of long-term methylphenidate use on growth and blood pressure: Results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS) 1.272
Pediatric acute-onset neuropsychiatric syndrome: A data mining approach to a very specific constellation of clinical variables 1.155
null 1.154
1H-NMR-Based Metabolomics in Autism Spectrum Disorder and Pediatric Acute-Onset Neuropsychiatric Syndrome 1.073
Methylphenidate long-term effects on psychiatric outcomes in a Sardinian ADHD population: preliminary results from the prospective ADDUCE project 1.032
Artificial neural networks analysis of polysomnographic and clinical features in pediatric acute-onset neuropsychiatric syndrome (Pans): From sleep alteration to “brain fog” 941
Long term methylphenidate exposure and growth in children and adolescents with ADHD. A systematic review and meta-analysis 909
Metabolomic Characterization of Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS) 873
Identifying Neurobiological Markers in Obsessive–Compulsive Disorder: A Study Protocol for a Cross-Sectional Study in Subgroups of Differing Phenotype 835
Profili cognitivi e disturbi psicopatologici. Evidenze neurobiologiche, diagnosi, trattamento 817
Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis 766
null 754
null 750
Omega-3/6 supplementation for mild to moderate inattentive ADHD: a randomised, double-blind, placebo-controlled efficacy study in Italian children 746
Neuropsychological characterization of aggressive behavior in children and adolescents with cd/odd and effects of single doses of medications: The protocol of the matrics_wp6-1 study 737
The pharmacological treatment of aggression in children and adolescents with conduct disorder. Do callous-unemotional traits modulate the efficacy of medication? 690
null 689
Disturbo Bipolare in età evolutiva: caratteristiche cliniche ed efficacia della terapia farmacologica 681
null 675
Pharmacological Treatment of Bipolar Depression: A Review of Observational Studies 673
null 658
Eziologia 634
Clinical characteristics, neuroimaging findings, and neuropsychological functioning in attention-deficit hyperactivity disorder: Sex differences 615
Neurofeedback for Attention-Deficit/Hyperactivity Disorder 601
The neuropsychological characterization of aggressive behaviour in children and adolescents with CD/ODD: preliminary results from a multicentric case-control study (MATRICS_consortium) 587
Association of Risk of Suicide Attempts With Methylphenidate Treatment 584
Methylphenidate effects on height and bone age in ADHD children. 24 month follow up within the prospective ADDUCE project 573
EFFICACY STUDY OF AN OMEGA-3/6 COMBINATION FOR MILD- TO MODERATE-INATTENTIVE ADHD: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL IN ITALIAN CHILDREN 559
Management and treatment of attention-deficit/hyperactivity disorder 551
null 549
Methylphenidate effects on social functioning in children with ADHD 546
Plasma poly-unsatured fatty acids profile in children with inattentive ADHD - preliminary results of an efficacy Italian study with omega 3/6 506
Paediatric European Risperidone Studies (PERS): context, rationale, objectives, strategy, and challenges. 470
Tolerability and safety of risperidone in childhood: may specific clinical variables predict extrapyramidal averse events? 458
Face and emotion recognition in children with ADHD and autism spectrum disorders: effects of methylphenidate 448
EffEtti sulla crescita della terapia a lungo termine con metilfenidato in bambini e adolescenti con disturbo da deficit di attenzione e iperattività (ADHD) 446
Contemporary diagnosis and treatment of conduct disorder in youth 398
Phenomenology and 24 month treatment outcome of pediatric bipolar disorder 333
Emotional dysregulation, executive functions and callous-unemotional traits in children and adolescents with Oppositional Defiant Disorder/Conduct Disorder and Autism Spectrum Disorder: a direct comparison 321
Long term therapy with methylphenidate induces modest effects on growth in ADHD children 318
Neuropsychiatric diseases of the basal ganglia: obsessive compulsive disorder, ADHD and Tourette Syndrome Neurobiology 300
Tolerability, safety and efficacy of long term (at least 6 months) quetiapine and aripiprazole in children and adolescents 297
Predictive factors for persistent use and compliance of immediate-release methylphenidate: A 36-month naturalistic study 293
Growth on stimulant medication: effects in children with ADHD 278
Neurobiologia della Depressione in Età Evolutiva 277
Research advances and future directions in female ADHD: the lifelong interplay of hormonal fluctuations with mood, cognition, and disease 264
Emotion recognition and social functioning in children with ADHD or autism spectrum disorders 264
The Impact of Methylphenidate on Pubertal Maturation and Bone Age in ADHD Children and Adolescents: Results from the ADHD Drugs Use Chronic Effects (ADDUCE) Project 211
Pandemic-related emergency psychiatric presentations for self-harm of children and adolescents in 10 countries (PREP-kids): a retrospective international cohort study 197
Long-term safety of methylphenidate in children and adolescents with ADHD: 2-year outcomes of the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study 183
Medication adherence and persistence in children and adolescents with attention deficit hyperactivity disorder (ADHD): a systematic review and qualitative update 181
ABA: l’analisi comportamentale applicata 168
Psicoterapia a indirizzo cognitivo-comportamentale 166
Long-term methylphenidate exposure and 24-hours blood pressure and left ventricular mass in adolescents and young adults with attention deficit hyperactivity disorder 163
An Evolutionary Preamble Towards a Multilevel Framework to Understand Adolescent Mental Health: An International Delphi Study 160
Methylphenidate and ADHD|Metilfenidato e ADHD 159
Professor Alessandro Zuddas’ Impact and Legacy: The Influential Networking and Human Connection Skills of a Passionate Scientist, Clinical Academic, and Pioneer in Child and Adolescent Psychopharmacology 150
Psychopharmacology in children and adolescents: unmet needs and opportunities 148
REM sleep atonia in patients with pediatric acute-onset neuropsychiatric syndrome (PANS): implications for pathophysiology 144
Computerized cognitive training in attention-deficit/hyperactivity disorder (ADHD): a meta-analysis of randomized controlled trials with blinded and objective outcomes 144
Lockdown stringency and paediatric self-harm presentations during COVID-19 pandemic: retrospective cohort study 144
Methylphenidate and Sleep Difficulties in Children and Adolescents With ADHD: Results From the 2-Year Naturalistic Pharmacovigilance ADDUCE Study 142
COVID-19 Pandemic School Disruptions and Acute Mental Health in Children and Adolescents 136
Remote assessment of ADHD in children and adolescents: recommendations from the European ADHD Guidelines Group following the clinical experience during the COVID-19 pandemic 136
Neurodevelopmental Disorders and Suicide: A Narrative Review 132
Self-Harm in Children and Adolescents Who Presented at Emergency Units During the COVID-19 Pandemic: An International Retrospective Cohort Study 119
Social and executive functioning in individuals with autism spectrum disorder without intellectual disability: The case–control study protocol of the CNeSA study 119
Neuropsichiatria infantile 114
Umbrella Review: Association Between Antipsychotic Drugs and Metabolic Syndrome Hallmarks in Children and Adolescents 108
An International Clinical Study of Ability and Disability in Autism Spectrum Disorder Using the WHO-ICF Framework 98
Editorial: Two Centimeters More or Less. How Much Does It Matter to an Adolescent or a Young Adult With Attention-Deficit/Hyperactivity Disorder? 80
Il disturbo oppositivo provocatorio 80
RISPERIDONE 73
Suicidal risk and psychopathological profiles in adolescents with neurodevelopmental disorders: an Italian multicentric study 73
Posttraumatic disorder, eye movement desensitization and reprocessing (EMDR) 68
Socioeconomic status and perception of well-being and mental health support: a three-year COVID-19 study in children with psychopathology and their parents 25
Comparing the Metabolic Profile of Patients Affected by Acute-Onset Neuropsychiatric Syndrome PANS and Tourette Syndrome: Preliminary Data 21
The microbiota–gut–brain axis as a modulator of symptom expression in autism spectrum disorder, with exploratory insights into ADHD: evidence from a structured narrative review on paediatric population 18
Attention deficit hyperactivity disorder symptoms and risky sexual behaviours in university students:the i-Share study 18
Totale 45.072
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.528
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.528
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.107 0 0 68 274 228 144 98 153 267 294 311 270
2022/20235.496 277 539 541 404 402 496 278 659 406 370 726 398
2023/20246.417 327 259 242 377 716 969 991 430 345 479 674 608
2024/202512.299 2.055 2.880 1.780 1.527 809 792 1.151 103 213 172 463 354
2025/20266.850 489 311 530 519 576 482 953 686 499 824 499 482
2026/20271.380 568 605 207 0 0 0 0 0 0 0 0 0
Totale 45.072